(Q46791436)

English

Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients

scientific article published in November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

phase III clinical trial

0 references

author name string

Richard J Benjamin

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

Jeffrey McCullough

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

Paul D Mintz

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

Edward Snyder

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

William D Spotnitz

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

Robert J Rizzo

6

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

David Wages

7

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

Jin-Sying Lin

8

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

Lindsey Wood

9

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

Laurence Corash

10

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

Maureen G Conlan

11

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

publication date

1 November 2005

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

45

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

11

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

1739-1749

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00583.X

21 January 2018

Current and emerging infectious risks of blood transfusions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00583.X

21 January 2018

Transmission of West Nile Virus through Blood Transfusion in the United States in 2002

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00583.X

21 January 2018

Factor VIII expression in azoxymethane-induced murine fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00583.X

21 January 2018

Fatigue during acute isovolemic anemiain healthy, resting humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00583.X

21 January 2018

Electrocardiographic ST-segment changes during acute, severe isovolemic hemodilution in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00583.X

21 January 2018

Human cardiovascular and metabolic response to acute, severe isovolemic anemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00583.X

21 January 2018

Effect of anaemia and cardiovascular disease on surgical mortality and morbidity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00583.X

21 January 2018

What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00583.X

21 January 2018

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00583.X

21 January 2018

Identifiers

10.1111/J.1537-2995.2005.00583.X

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16271099

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46791436&oldid=2132240196"